|
Characteristics
|
ΔNLR(%)
|
ΔCLC(%)
|
ΔCPC(%)
|
|---|
|
ART+IMRT
|
IMRT
|
P
|
ART+IMRT
|
IMRT
|
P
|
ART+IMRT
|
IMRT
|
P
|
|---|
|
T stage
|
|
1–2(n = 30)
|
15.61 ± 65.69
|
59.03 ± 58.52
|
0.018*
|
−117.93 ± 88.14
|
−406.47 ± 350.15
|
< 0.001*
|
−6.80 ± 20.87
|
−19.07 ± 34.61
|
0.107
|
|
3–4(n = 20)
|
−27.92 ± 157.78
|
57.65 ± 34.57
|
0.032*
|
−138.93 ± 155.13
|
−243.70 ± 240.36
|
0.095
|
−1.1 ± 26.93
|
−12.96 ± 29.24
|
0.199
|
|
N stage
|
|
0–1(n = 18)
|
2.17 ± 130.78
|
76.54 ± 12.69
|
0.029*
|
−109.18 ± 107.03
|
− 312.87 ± 219.52
|
0.003*
|
−6.21 ± 24.70
|
−18.57 ± 25.47
|
0.171
|
|
2–3(n = 32)
|
−4.03 ± 107.59
|
66.85 ± 61.10
|
0.004*
|
− 135.98 ± 129.10
|
− 357.39 ± 372.84
|
0.003*
|
−3.58 ± 22.97
|
−15.53 ± 36.05
|
0.117
|
- Abbreviations: ART adaptive radiotherapy, IMRT Intensity-modulated radiotherapy, NLR neutrophil-to-lymphocyte ratio, CLC circulating lymphocyte count; CPC, circulating platelet count
- *P ≤ 0.05
